TG Therapeutics, Inc. Common Stock (NASDAQ: TGTX) last traded at $54.27, up 7.34% on the session. The quote above updates while this page is open; the figures below are drawn from TG Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
TG Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TGTX. Its market capitalisation is $8.31 billion.
Valuation measures for TG Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.31B |
|---|---|
| Enterprise value | $8.86B |
| P/E ratio | 19.81 |
| Price / sales | 10.39 |
| Price / book | 13.75 |
| Beta | 0.60 |
Trailing-twelve-month figures tagged in TG Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $799.54M |
|---|---|
| Net income (TTM) | $441.49M |
| EPS (TTM) | $2.74 |
| Operating margin | 17.05% |
| Return on equity | 73.08% |
| Cash | $482.57M |
Range and volume for TGTX over the past 52 weeks.
| 52-week high | $59.30 |
|---|---|
| 52-week low | $26.76 |
| Volume | 5.38M |
| Average volume | 2.44M |
| Previous close | $50.56 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.